🇺🇸 FDA
Patent

US 7413864

Treating cancer using a telomerase vaccine

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7413864 (Treating cancer using a telomerase vaccine) held by The Regents of the University of Colorado expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00